<DOC>
	<DOCNO>NCT00419744</DOCNO>
	<brief_summary>The purpose study determine SYMBICORT® deliver via pressurize metered-dose inhaler , refer pMDI , effective prevent COPD exacerbation .</brief_summary>
	<brief_title>A Comparison SYMBICORT® pMDI With Formoterol Turbuhaler® Subjects With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>A current clinical diagnosis COPD COPD symptoms 2 year Current smoker smoke history 10 pack year ( 1 pack year = 20 cigarette smoke per day one year ) A history least 1 COPD exacerbation require course steroid and/or antibiotic within 112 month first visit A history asthma 18 year age A history allergic rhinitis 18 year age Subjects take oral steroid Any significant disease disorder may jeopardize subject 's safety</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>COPD</keyword>
</DOC>